Pioglitazone alleviates cardiac and vascular remodelling and improves survival in monocrotaline induced pulmonary arterial hypertension.
Behringer A, Trappiel M, Berghausen EM, Ten Freyhaus H, Wellnhofer E, Odenthal M, Blaschke F, Er F, Gassanov N, Rosenkranz S, Baldus S, Kappert K, Caglayan E.
Behringer A, et al. Among authors: ten freyhaus h.
Naunyn Schmiedebergs Arch Pharmacol. 2016 Apr;389(4):369-79. doi: 10.1007/s00210-015-1205-3. Epub 2016 Jan 7.
Naunyn Schmiedebergs Arch Pharmacol. 2016.
PMID: 26742933